Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Toney

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Behavioural Brain Research|October 1, 1984
Ineffectiveness of cholecystokinin in impairing runway performanceJ E Cox, P T Brown, R J Toney, et al.
Clinical and Translational Medicine|August 20, 2024
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumoursMeghali Goswami, Nicole J Toney, Stephanie C Pitts, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 managementJennifer L Marté, Nicole J Toney, Lisa Cordes, et al.
The Journal of Biological Chemistry|August 25, 1989
Selective inhibition of protein disulfide isomerase by estrogensJ C Tsibris, L T Hunt, G Ballejo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assaysM W Beckmann, L J Toney, A Scharl, et al.
Journal for Immunotherapy of Cancer|April 24, 2025
Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapyNicole J Toney, Megan T Lynch, Filipa Lynce, et al.
Journal for Immunotherapy of Cancer|March 12, 2021
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemicRenee N Donahue, Jennifer L Marté, Meghali Goswami, et al.
International Immunopharmacology|May 26, 2023
Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12Nicole J Toney, Margaret E Gatti-Mays, Nicholas P Tschernia, et al.
Journal of Inorganic Biochemistry|November 23, 2019
Evaluation of the regulatory model for Ni<sup>2+</sup> sensing by Nur from Streptomyces coelicolorOlivia M Manley, Paisley D Myers, Denise J Toney, et al.
Scientific Reports|January 17, 2025
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Behavioural Brain Research|October 1, 1984
Ineffectiveness of cholecystokinin in impairing runway performanceJ E Cox, P T Brown, R J Toney, et al.
Clinical and Translational Medicine|August 20, 2024
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumoursMeghali Goswami, Nicole J Toney, Stephanie C Pitts, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 managementJennifer L Marté, Nicole J Toney, Lisa Cordes, et al.
The Journal of Biological Chemistry|August 25, 1989
Selective inhibition of protein disulfide isomerase by estrogensJ C Tsibris, L T Hunt, G Ballejo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assaysM W Beckmann, L J Toney, A Scharl, et al.
Journal for Immunotherapy of Cancer|April 24, 2025
Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapyNicole J Toney, Megan T Lynch, Filipa Lynce, et al.
Journal for Immunotherapy of Cancer|March 12, 2021
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemicRenee N Donahue, Jennifer L Marté, Meghali Goswami, et al.
International Immunopharmacology|May 26, 2023
Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12Nicole J Toney, Margaret E Gatti-Mays, Nicholas P Tschernia, et al.
Journal of Inorganic Biochemistry|November 23, 2019
Evaluation of the regulatory model for Ni<sup>2+</sup> sensing by Nur from Streptomyces coelicolorOlivia M Manley, Paisley D Myers, Denise J Toney, et al.
Scientific Reports|January 17, 2025
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Pageof 4